The Clorox Company (NYSE:CLX) Receives $143.33 Consensus PT from Analysts

Shares of The Clorox Company (NYSE:CLX) have earned a consensus recommendation of “Reduce” from the seventeen ratings firms that are presently covering the firm, MarketBeat reports. Six investment analysts have rated the stock with a sell rating and eleven have assigned a hold rating to the company. The average 12-month target price among brokers that have covered the stock in the last year is $143.33.

Several research firms have recently commented on CLX. Barclays lifted their target price on Clorox from $122.00 to $130.00 and gave the company an “underweight” rating in a research note on Monday, August 5th. BNP Paribas upgraded Clorox to a “strong sell” rating in a research report on Friday, September 6th. TD Cowen initiated coverage on shares of Clorox in a research report on Tuesday, July 23rd. They set a “sell” rating and a $122.00 target price on the stock. JPMorgan Chase & Co. reduced their target price on shares of Clorox from $150.00 to $148.00 and set a “neutral” rating on the stock in a research note on Friday, August 2nd. Finally, Deutsche Bank Aktiengesellschaft increased their price objective on shares of Clorox from $144.00 to $151.00 and gave the company a “hold” rating in a report on Friday, August 2nd.

Clorox Stock Up 0.9 %

Shares of NYSE CLX opened at $163.42 on Tuesday. The company has a quick ratio of 0.63, a current ratio of 1.03 and a debt-to-equity ratio of 5.04. The company has a market cap of $20.29 billion, a price-to-earnings ratio of 84.67, a price-to-earnings-growth ratio of 3.31 and a beta of 0.40. Clorox has a 12-month low of $114.68 and a 12-month high of $169.09. The firm’s 50-day simple moving average is $151.92 and its 200 day simple moving average is $144.14.

Clorox (NYSE:CLX) last released its quarterly earnings results on Thursday, August 1st. The company reported $1.82 EPS for the quarter, beating the consensus estimate of $1.54 by $0.28. The business had revenue of $1.90 billion for the quarter, compared to analysts’ expectations of $1.97 billion. Clorox had a net margin of 3.95% and a return on equity of 281.12%. On average, research analysts expect that Clorox will post 6.63 earnings per share for the current fiscal year.

Clorox Announces Dividend

The firm also recently announced a quarterly dividend, which will be paid on Thursday, November 7th. Shareholders of record on Wednesday, October 23rd will be issued a dividend of $1.22 per share. The ex-dividend date of this dividend is Wednesday, October 23rd. This represents a $4.88 annualized dividend and a yield of 2.99%. Clorox’s dividend payout ratio is presently 252.85%.

Insiders Place Their Bets

In other news, EVP Angela C. Hilt sold 1,733 shares of Clorox stock in a transaction dated Friday, September 6th. The stock was sold at an average price of $165.52, for a total transaction of $286,846.16. Following the transaction, the executive vice president now owns 13,471 shares in the company, valued at approximately $2,229,719.92. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is available at the SEC website. Corporate insiders own 0.51% of the company’s stock.

Institutional Inflows and Outflows

Institutional investors have recently bought and sold shares of the stock. Corient Private Wealth LLC raised its holdings in shares of Clorox by 7.1% during the fourth quarter. Corient Private Wealth LLC now owns 33,570 shares of the company’s stock worth $4,787,000 after acquiring an additional 2,230 shares during the period. Cambridge Investment Research Advisors Inc. lifted its holdings in shares of Clorox by 1.0% in the fourth quarter. Cambridge Investment Research Advisors Inc. now owns 48,102 shares of the company’s stock valued at $6,859,000 after purchasing an additional 498 shares in the last quarter. Team Hewins LLC acquired a new position in shares of Clorox during the fourth quarter worth about $203,000. Orion Portfolio Solutions LLC grew its holdings in shares of Clorox by 40.8% during the fourth quarter. Orion Portfolio Solutions LLC now owns 36,963 shares of the company’s stock worth $5,257,000 after buying an additional 10,704 shares in the last quarter. Finally, Advisory Services Network LLC raised its position in Clorox by 39.4% in the 4th quarter. Advisory Services Network LLC now owns 19,507 shares of the company’s stock valued at $2,782,000 after buying an additional 5,510 shares during the last quarter. Institutional investors own 78.53% of the company’s stock.

Clorox Company Profile

The Clorox Company manufactures and markets consumer and professional products worldwide. It operates through four segments: Health and Wellness, Household, Lifestyle, and International. The Health and Wellness segment offers cleaning products, such as laundry additives and home care products primarily under the Clorox, Clorox2, Scentiva, Pine-Sol, Liquid-Plumr, Tilex, and Formula 409 brands; professional cleaning and disinfecting products under the CloroxPro and Clorox Healthcare brands; professional food service products under the Hidden Valley brand; and vitamins, minerals and supplement products under the RenewLife, Natural Vitality, NeoCell, and Rainbow Light brands in the United States.